• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (NQ:QNTM)

    7.810 +0.810 (+11.57%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 476,252
    Open 7.230
    Bid (Size) 7.510 (5,100)
    Ask (Size) 7.910 (100)
    Prev. Close 7.000
    Today's Range 6.700 - 8.240
    52wk Range 2.070 - 38.25
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reports Midpoint Enrollment Milestone in Multiple Sclerosis Imaging Study
    Via Investor Brand Network
    News headline image
    Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital
    Promising Early Data Strengthens Potential of Novel PET Technology to Advance Development of Lucid-MS for Multiple Sclerosis 
    From Quantum BioPharma
    Via GlobeNewswire

    Performance

    YTD
    +11.4%
    +11.4%
    1 Month
    +150.3%
    +150.3%
    3 Month
    +114.6%
    +114.6%
    6 Month
    +23.8%
    +23.8%
    1 Year
    -31.4%
    -31.4%

    More News

    Read More
    News headline image
    Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026
    From Quantum BioPharma
    Via GlobeNewswire
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant
    From Quantum BioPharma
    Via GlobeNewswire
    News headline image
    Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied
    From Quantum BioPharma
    Via GlobeNewswire
    News headline image
    Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis
    From Quantum BioPharma
    Via GlobeNewswire
    News headline image
    Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis
    From Quantum BioPharma
    Via GlobeNewswire
    Friday's after hours session: top gainers and losers ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status
    From Quantum BioPharma
    Via GlobeNewswire
    News headline image
    Quantum Biopharma Announces Appointment of Principal Investigator for Planned Phase 2 Clinical Trial of Lucid-21-302 (Lucid-MS) in Multiple Sclerosis
    From Quantum BioPharma
    Via GlobeNewswire
    These stocks are moving in today's session ↗
    Via Chartmill
    Top movers in Tuesday's session ↗
    Via Chartmill
    What's going on in today's session ↗
    Via Chartmill
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd
    From Quantum BioPharma
    Via GlobeNewswire
    Which stocks have an unusual volume on Friday? ↗
    Via Chartmill
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    QNTM DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026
    Via NewMediaWire
    Topics Law Enforcement Lawsuit
    News headline image
    QNTM DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026
    Via TheNewswire.com
    Topics Law Enforcement Lawsuit

    Frequently Asked Questions

    Is Quantum Biopharma Ltd. - Class B Subordinate Voting Shares publicly traded?
    Yes, Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is publicly traded.
    What exchange does Quantum Biopharma Ltd. - Class B Subordinate Voting Shares trade on?
    Quantum Biopharma Ltd. - Class B Subordinate Voting Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Quantum Biopharma Ltd. - Class B Subordinate Voting Shares?
    The ticker symbol for Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is QNTM on the Nasdaq Stock Market
    What is the current price of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares?
    The current price of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is 7.810
    When was Quantum Biopharma Ltd. - Class B Subordinate Voting Shares last traded?
    The last trade of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares was at 05/20/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.